Allison E. Cherry
Impact in
-
- Neuroscience and Neuropharmacology Research
- Genetic Neurodegenerative Diseases
- Pharmacology top 10%
- Cannabis and Cannabinoid Research
Papers in
-
- Genomics and Chromatin Dynamics 2
- Receptor Mechanisms and Signaling 2
- Epigenetics and DNA Methylation 1
-
- Neuroscience and Neuropharmacology Research 3
- Co-authors
- Nephi Stella (7 shared papers)Stephanie C. Stotz (1 shared paper)Igor Splawski (1 shared paper)David E. Clapham (1 shared paper)Mark T. Keating (1 shared paper)Dana Yoo (1 shared paper)Susan Fung (4 shared papers)Eric A. Horne (3 shared papers)
- Journals
- Glia (2 papers)Molecular Cancer Therapeutics (1 paper)Neuroscience (1 paper)Neuron (1 paper)European Journal of Neuroscience (1 paper)
- Partner nations
- United StatesNetherlandsSwitzerland
In The Last Decade
Allison E. Cherry
11 papers receiving 497 citations
Peers
Comparison fields: 5 of 72
- Cellular and Molecular Neuroscience 181
- Pharmacology 111
- Cognitive Neuroscience 92
- Molecular Biology 281
- Genetics 91
Countries citing papers authored by Allison E. Cherry
This map shows the geographic impact of Allison E. Cherry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Allison E. Cherry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Allison E. Cherry more than expected).
Fields of papers citing papers by Allison E. Cherry
This network shows the impact of papers produced by Allison E. Cherry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Allison E. Cherry. The network helps show where Allison E. Cherry may publish in the future.
Co-authors
The 25 scholars most cited alongside Allison E. Cherry, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 205 | |
| 2 | 2014 | 95 | |
| 3 | 2018 | 47 | |
| 4 | 2012 | 45 | |
| 5 | 2014 | 38 | |
| 6 | 2016 | 23 | |
| 7 | 2019 | 15 | |
| 8 | 2008 | 15 | |
| 9 | 2015 | 15 | |
| 10 | 2016 | 9 | |
| 11 | The Pros of Cons | 2018 | 1 |
About Allison E. Cherry
Allison E. Cherry is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience, Pharmacology, Cognitive Neuroscience and Cell Biology, having authored 11 papers that have together received 508 indexed citations. Recurring topics across this work include Neuroscience and Neuropharmacology Research (3 papers), Genomics and Chromatin Dynamics (2 papers), Cannabis and Cannabinoid Research (2 papers), Receptor Mechanisms and Signaling (2 papers), Autism Spectrum Disorder Research (1 paper), Advanced Proteomics Techniques and Applications (1 paper), Epigenetics and DNA Methylation (1 paper) and Genetics and Neurodevelopmental Disorders (1 paper). The work is most often cited by research in Cellular and Molecular Neuroscience (181 citations), Pharmacology (111 citations), Cognitive Neuroscience (92 citations), Molecular Biology (281 citations) and Genetics (91 citations). Allison E. Cherry has collaborated with scholars based in United States, Netherlands and Switzerland. Frequent co-authors include Nephi Stella, Stephanie C. Stotz, Igor Splawski, David E. Clapham, Mark T. Keating, Dana Yoo, Susan Fung, Eric A. Horne, Alipi V. Naydenov and William Marrs. Their work appears in journals such as Glia, Molecular Cancer Therapeutics, Neuroscience, Neuron and European Journal of Neuroscience.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.